Garcia, J. R. (2025). A phase I, multicenter, open-label study of UB-VV111 in combination with rapamycin in relapsed/refractory CD19+ B-cell malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2681